[February 26, 2015]

SynteractHCR Expands Senior Management Team with Appointment of Etienne Drouet as Vice President, Strategic Development

SynteractHCR, a full-service, international contract research organization (CRO), has hired Etienne Drouet as vice president, strategic development. This is a new position created to augment the depth of the company's oncology and complex trial expertise. Adding experience to an already capable senior management team brings new perspectives and enhances the team's skills as this global CRO continues its focus on the small and mid-size biopharma segment.

Etienne Drouet has more than 20 years of experience in executive leadership, program and project management, clinical trial management, and research and development within the contract research and biopharmaceutical industries. At SynteractHCR he will join the senior management team, helping to develop company strategy and business models. His primary objective will be to ensure excellence in operational delivery to clients. He will report directly to CEO Wendel Barr.

"Since we work with smaller and mid-sized companies on complex global trials, integrating his extensive drug development knowledge is key to further improving bot the strategic thinking and executional support our clients request," said Wendel Barr, CEO of SynteractHCR. "We are delighted to have him on board the team."

Drouet joins SynteractHCR from Premier Research, where he was executive director, global oncology. Previously he was a program manager and senior project manager at ICON; held project management positions at AAI Pharma and Cvitkovic and Associés Consultants; was a senior CRA at the Breast Cancer International Research Group; and a research scientist with Sanofi Aventis. Drouet has notable therapeutic experience in solid tumor and hematological cancers as well as CNS (central nervous systems).

He has an engineering degree in Biotechnology from the European School of Biotechnology in Strasbourg. Etienne Drouet also holds a Master in Science with a major in Cell Biology, Molecular Genetics, and Virology from the University Louis Pasteur in Strasbourg, Alsace, France.

About SynteractHCR (www.synteracthcr.com)

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and 60 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its "Shared Work - Shared Vision" philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.

[ Back To TMCnet.com's Homepage ]